(Q35964138)

11 August 2017

1 reference

title

[18F]FLT-PET in oncology: current status and opportunities (English)

1 reference

11 August 2017

Lukas B Been

1

1 reference

11 August 2017

Albert J H Suurmeijer

2

1 reference

11 August 2017

David C P Cobben

3

1 reference

11 August 2017

Pieter L Jager

4

1 reference

11 August 2017

Harald J Hoekstra

5

1 reference

11 August 2017

Philip H Elsinga

6

1 reference

11 August 2017

1 December 2004

1 reference

11 August 2017

14

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

11 August 2017

31

1 reference

11 August 2017

12

1 reference

11 August 2017

1659-1672

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-004-1687-6

11 August 2017

0 references

cites work

Early changes in [18F]FLT uptake after chemotherapy: an experimental study

1 reference

12 December 2020

3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?

1 reference

12 December 2020

3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules.

1 reference

12 December 2020

In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy.

1 reference

12 December 2020

Sentinel lymphadenectomy in breast cancer

1 reference

12 December 2020

Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging

1 reference

12 December 2020

Brain tumor imaging with PET and 2-[carbon-11]thymidine.

1 reference

12 December 2020

Purine and pyrimidine metabolism in human gliomas: relation to chromosomal aberrations

1 reference

12 December 2020

FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models

1 reference

12 December 2020

Human thymidine kinase 1. Regulation in normal and malignant cells

1 reference

12 December 2020

Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma

1 reference

12 December 2020

In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography

1 reference

12 December 2020

Enhanced in vitro inhibition of HIV-1 replication by 3'-fluoro-3'-deoxythymidine compared to several other nucleoside analogs

1 reference

12 December 2020

Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine

1 reference

12 December 2020

Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity

1 reference

12 December 2020

Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[(18)F]fluoro-3'-deoxythymidine ([(18)F]FLT) in pancreatic cancer cell lines.

1 reference

12 December 2020

Relationship between plasma concentrations of 3'-deoxy-3'-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials.

1 reference

12 December 2020

Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs

1 reference

12 December 2020

Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?

1 reference

12 December 2020

Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.

1 reference

12 December 2020

Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer

1 reference

12 December 2020

18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET.

1 reference

12 December 2020

Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.

1 reference

12 December 2020

Thymidine concentrations in serum and urine of different animal species and man

1 reference

12 December 2020

Synthesis of 2'-deoxy-2'-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU.

1 reference

12 December 2020

Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.

1 reference

12 December 2020

Detection and grading of soft tissue sarcomas of the extremities with (18)F-3'-fluoro-3'-deoxy-L-thymidine.

1 reference

12 December 2020

Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value

1 reference

12 December 2020

Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells

1 reference

12 December 2020

In vitro and animal validation of bromine-76-bromodeoxyuridine as a proliferation marker.

1 reference

12 December 2020

Radiosynthesis of 3'-deoxy-3'-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo

1 reference

12 December 2020

Cell cycle regulation of thymidine kinase: residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis

1 reference

12 December 2020

Potential impact of [ 18 F]3'-deoxy-3'-fluorothymidine versus [ 18 F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancer

1 reference

12 December 2020

The Ki-67 protein: from the known and the unknown

1 reference

12 December 2020

3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease.

1 reference

12 December 2020

Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis

1 reference

12 December 2020

Effectiveness of positron emission tomography for the detection of melanoma metastases

1 reference

12 December 2020

3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.

1 reference

12 December 2020

[18F]FLT PET for diagnosis and staging of thoracic tumours

1 reference

12 December 2020

Enhanced expression of thymidine kinase in human cells following ionizing radiation.

1 reference

12 December 2020

Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides

1 reference

12 December 2020

Synthesis of 2'-fluoro-5-[11C]-methyl-1-beta-D-arabinofuranosyluracil ([11C]-FMAU): a potential nucleoside analog for in vivo study of cellular proliferation with PET.

1 reference

12 December 2020

Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.

1 reference

12 December 2020

Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation.

1 reference

12 December 2020

FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma

1 reference

12 December 2020

2-[C-11]thymidine imaging of malignant brain tumors.

1 reference

12 December 2020

L-[1-11C]-tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer

1 reference

12 December 2020

Structural modifications at the 2'- and 3'-positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporter

1 reference

12 December 2020

Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs

1 reference

12 December 2020

Proliferation in non-Hodgkin's lymphomas as determined by immunohistochemical double staining for Ki-67

1 reference

12 December 2020

Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma.

1 reference

12 December 2020

A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer

1 reference

12 December 2020

Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients

1 reference

12 December 2020

In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumor

1 reference

12 December 2020

PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls

1 reference

12 December 2020

FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence.

1 reference

12 December 2020

Evaluation of serum CA27.29, CA15-3 and CEA in patients with breast cancer

1 reference

12 December 2020

The role of FDG-PET scan in staging patients with nonsmall cell carcinoma

1 reference

12 December 2020

PET scan imaging in oncology

1 reference

12 December 2020

In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanoma

1 reference

12 December 2020

High radiochemical yield synthesis of 3'-deoxy-3'-[18F]fluorothymidine using (5'-O-dimethoxytrityl-2'-deoxy-3'-O-nosyl-beta-D-threo pentofuranosyl)thymine and its 3-N-BOC-protected analogue as a labeling precursor

1 reference

12 December 2020

PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study

1 reference

12 December 2020

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

1 reference

12 December 2020

10.1007/S00259-004-1687-6

Identifiers

DOI

1 reference

11 August 2017

1 reference